Anavex Life Sciences Corp (AVXL)

[ExtremelyBullishZig]

The most plausible reason for both the drip in share price and the omitted AD from 3-71 is that Anavex has realized AD is not in the cards.

Many other reasons might be mentioned, but only 2 other reasons make sense. There a ton of other indications on the pipeline that won't have trials initiated anytime soon, so why keep them on the chart and leave the most notable one to date off.

Not wanting to have 2 AD drugs on the market doesn't make sense aland would be a sick and twisted scenario...yet the WGT crowd is excited about that being the reason. The same people who said "2-73 is the treatment and 3-71 is the cure". That is a horrible thing to do...wish a treatment make money and leave the cure off the table until 2-73 has reached its market potential. I can't believe I read such ideas from the WGT crowd...sick, twisted, monsters.

Anavex either wants to do that unthinkable scenario or they have decided that AD is over...other indications work better because the Sigma1 receptor is much available in no AD patients...in younger patients, etc.

That is the only reason you would remove an indication at this time when the most viewers are watching...just like when they removes MS.